Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sunisa Kaewpaiboon"'
Publikováno v:
Advances in Science and Technology.
Antibiotic-resistant has emerged without new drug challenges. Polymyxin B (PMB) was the last resort therapy for multiple-drug resistant Gram-negative bacteria. However, the toxicity of PMB including nephrotoxicity (61%) and neurotoxicity (7%) was dos
Publikováno v:
Colloids and Surfaces A: Physicochemical and Engineering Aspects. 660:130816
Autor:
Sunisa Kaewpaiboon, Teerapol Srichana
Publikováno v:
Journal of pharmaceutical sciences. 111(8)
Polymyxin B (PMB) and sodium deoxycholate sulfate (SDCS) ratios were optimized. The self-assembly of PMB-SDCS was characterized using dynamic light scattering. Five different mole ratios of SDCS to PMB (5:1, 10:1, 15:1, 30:1, and 45:1) were prepared
Autor:
Charisopon Chunhachaichana, Teerapol Srichana, Sunisa Kaewpaiboon, Tan Suwandecha, Sukanjana Kamlungmak, Muhammad Ali Khumaini Mudhar Bintang, Supattra Prom-In, Titpawan Nakpheng
Publikováno v:
Biologicalpharmaceutical bulletin. 44(11)
Mupirocin nanoparticle-loaded hydrogel (MLH) was successfully developed. This study focused on the safety of cell lines and the biocompatibility of MLH for wound healing in rat models. MLH was assessed by an analysis of cytotoxicity and the secretion
Autor:
Teerapol Srichana, Sunisa Kaewpaiboon, Surapee Tiengrim, Zaheer Ul-Haq, Titpawan Nakpeng, Ruqaiya Khalil, Visanu Thamlikitkul, Kittiya Tinpun, Pornvichai Temboot
Publikováno v:
Journal of Drug Delivery Science and Technology. 58:101779
Polymyxin B (PMB) is used as the last line therapy for multidrug-resistant Gram-negative bacterial infections; however, nephrotoxicity is still a concern. Here, PMB carried with sodium deoxycholate sulfate (SDCS) was developed, which aimed to improve